LAB B Income Statement - TTM - Genomma Lab Internacional, S.A.B. de C.V.

Income Statement (TTM)

Genomma Lab Internacional, S.A.B. de C.V. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	13,619	13,870	14,083	14,312	14,868	15,487	15,954	16,412	16,778	16,820	16,983	17,030	17,074	16,467	16,486	16,767	17,466	18,607	18,816	18,841
Change (%)		1.84	1.54	1.63	3.88	4.16	3.02	2.87	2.23	0.25	0.97	0.28	0.26	-3.56	0.12	1.70	4.17	6.53	1.12	0.13
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	5,163	5,282	5,376	5,432	5,723	5,924	6,058	6,255	6,390	6,656	6,769	6,764	6,752	6,384	6,227	6,195	6,364	6,676	6,857	6,890
Change (%)		2.30	1.78	1.04	5.36	3.51	2.27	3.25	2.15	4.17	1.70	-0.07	-0.18	-5.45	-2.46	-0.51	2.73	4.89	2.72	0.48
% of Revenue	37.91	38.08	38.18	37.95	38.49	38.25	37.97	38.11	38.08	39.57	39.86	39.72	39.55	38.77	37.77	36.95	36.44	35.88	36.44	36.57

Gross Operating Profit	8,456	8,588	8,707	8,880	9,145	9,563	9,896	10,157	10,388	10,164	10,214	10,266	10,322	10,083	10,259	10,572	11,102	11,931	11,959	11,950
Change (%)		1.56	1.38	1.99	2.98	4.57	3.48	2.64	2.27	-2.16	0.50	0.51	0.55	-2.31	1.74	3.05	5.01	7.47	0.23	-0.07
% of Revenue	62.09	61.92	61.82	62.05	61.51	61.75	62.03	61.89	61.92	60.43	60.14	60.28	60.45	61.23	62.23	63.05	63.56	64.12	63.56	63.43

SG&A	5,899	5,666	5,736	5,872	6,135	6,570	6,877	7,043	7,185	6,922	6,932	7,002	6,988	6,889	6,965	7,121	7,303	8,055	7,979	7,944
Change (%)		-3.95	1.24	2.36	4.48	7.10	4.67	2.42	2.02	-3.66	0.13	1.01	-0.19	-1.42	1.10	2.24	2.56	10.29	-0.95	-0.44
% of Revenue	43.32	40.85	40.73	41.03	41.26	42.42	43.10	42.91	42.83	41.16	40.81	41.11	40.93	41.83	42.24	42.47	41.81	43.29	42.40	42.16

R&D
Change (%)
% of Revenue

OpEx	11,012	11,101	11,268	11,470	11,974	12,431	12,809	13,170	13,459	13,576	13,711	13,727	13,744	13,260	13,226	13,394	13,800	14,693	14,799	14,777
Change (%)		0.81	1.50	1.79	4.40	3.81	3.05	2.81	2.20	0.87	0.99	0.11	0.13	-3.52	-0.26	1.28	3.03	6.47	0.72	-0.15
% of Revenue	80.86	80.04	80.01	80.14	80.53	80.27	80.29	80.24	80.22	80.72	80.73	80.60	80.50	80.52	80.22	79.88	79.01	78.97	78.65	78.43

Operating Income	2,607	2,769	2,815	2,842	2,894	3,056	3,145	3,243	3,319	3,244	3,272	3,303	3,330	3,207	3,261	3,373	3,666	3,913	4,017	4,064
Change (%)		6.21	1.67	0.96	1.82	5.60	2.89	3.11	2.34	-2.26	0.88	0.95	0.80	-3.68	1.67	3.44	8.71	6.74	2.64	1.18
% of Revenue	19.14	19.96	19.99	19.86	19.47	19.73	19.71	19.76	19.78	19.28	19.27	19.40	19.50	19.48	19.78	20.12	20.99	21.03	21.35	21.57

Interest Expense	-500	-461	-420	-389	-463	-444	-461	-507	-463	-526	-607	-703	-774	-830	-849	-877	-900	-888	-907	-851
Change (%)		-7.76	-8.97	-7.27	18.98	-4.04	3.64	10.04	-8.67	13.57	15.57	15.66	10.13	7.25	2.24	3.41	2.52	-1.31	2.19	-6.18
% of Revenue	-3.67	-3.32	-2.98	-2.72	-3.11	-2.87	-2.89	-3.09	-2.76	-3.13	-3.58	-4.13	-4.53	-5.04	-5.15	-5.23	-5.15	-4.77	-4.82	-4.52

Net Income	1,179	1,404	1,416	1,368	1,352	1,308	1,328	1,353	1,359	1,366	1,408	1,421	1,392	1,085	1,099	1,313	1,603	2,091	2,218	1,941
Change (%)		19.02	0.90	-3.42	-1.16	-3.25	1.51	1.92	0.45	0.53	3.04	0.90	-2.01	-22.06	1.30	19.49	22.04	30.48	6.05	-12.48
% of Revenue	8.66	10.12	10.06	9.56	9.09	8.44	8.32	8.24	8.10	8.12	8.29	8.34	8.15	6.59	6.67	7.83	9.18	11.24	11.79	10.30

Source: Capital IQ

Genomma Lab Internacional, S.A.B. de C.V. - Income Statement (TTM)

Income Statement (TTM)

Other Listings

US:GNMLF
DE:GEKA	€1.00